Should persons with acute myeloid leukemia (AML) in 1st histological complete remission who are measurable residual disease (MRD) test positive receive an allotransplant?
Sign Up to like & getrecommendations! Published in 2020 at "Leukemia"
DOI: 10.1038/s41375-020-0780-6
Abstract: Mathew 25:29. Increased understanding of the biology of acute myeloid leukemia (AML) has encouraged development of individualized therapy strategies, which focus on identifying which persons are likely to benefit from which interventions [1]. An example… read more here.
Keywords: histological complete; complete remission; 1st histological; remission ... See more keywords